SECO

The gel was investigated in a case series, which was presented in a poster at SECO 2025.

Julie Rodman, OD, MS, FAAO, sits down with Optometry Times to discuss her anticipation for the future of technology in optometry, especially retinal care.

Horace Deal, OD, will serve a 2024-2025 term and brings nearly 30 years of optometric experience to the position.

The eye care device company has announced that MARLO has gone mobile with a new app, which allows patients to order contact lenses, perform vision screening, and access eye disease and care information.

Paul Chous, MA, OD, FAAO, shares key highlights from his 2023 SECO presentation looking at sleep disorders and how they play a role in eye disease.

In Atlanta, Georgia, the OIS @ SECO Innovation Showcase highlighted the best and the brightest optometric and ophthalmic drugs, therapies, and tech we hope to see come to fruition.

Andy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."

Nate Lighthizer, OD, gives highlights from his SECO 2023 presentation, "The glaucoma compass."

Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.

Mile Brujic, OD, shares highlights from his SECO 2023 presentation, "Learning about the Lid: Optimizing recognition, diagnosis, and treatment of Demodex blepharitis and blepharoptosis."

Mile Brujic, OD, shares highlights from his SECO 2023 poster presentation on confocal scanning laser imaging and patient care.

Chris Wroten, OD, shares key takeaways from his "Hot news or not news?" presentation at SECO 2023.

Nate Lighthizer, OD, shares what to expect from his SECO workshop, "Lasers in Optometry: The Next Frontier."

Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.

Mohammed Rafieetary, OD, shares key takeaways from his SECO 2023 presentation, "Advancing the understanding of geographic atrophy."

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."

Paul Chous, MA, OD, FAAO, gives key takeaways from his 2023 SECO presentation on diabetes: then and now.

Chris Wroten, OD, shares highlights from the hands-on laser workshop he co-led during SECO 2023.

Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key takeaways from his SECO 2023 presentation, "Drugs of the future."

Shalu Pal, BSc, OD, FAAO, shares key takeaways from the contact lens zpanel discussion she participated in.

Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key highlights from his portion of the "Presbyopia management panel," during SECO 2023 in Atlanta.

Carly Rose, OD, FAAO, shares her experience and patient feedback on implementing the first and only FDA-approved nasal spray for dry eye treatment.

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma